DALLAS--(BUSINESS WIRE)--Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced ...

Scientists have made a leap in genetic engineering by pushing elephant cells into an embryonic-like state. This marks a major step toward recreating traits of the extinct woolly mammoth, offering new ...

The start-up Colossal Biosciences aims to use gene-editing technology to bring back the woolly mammoth and other extinct species. Recently, the company achieved major milestones: last year, they ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists at the Dallas-based Colossal Biosciences have taken a big step towards their goal of bringing back the woolly mammoth ...

When the elevator doors part on the second floor of a two-story brick and glass building in an office park on the outskirts of downtown Dallas, it feels like a portal opening to a different world. The ...

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly mammoth from extinction. In a preprint paper published on March 4, scientists at ...

It’s one small step for mice, one giant leap for mammoth-kind. Scientists endeavoring to “de-extinct” woolly mammoths through genetic modification have taken a meaningful step toward achieving their ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. Colossal Biosciences is now valued at over $10 billion and ...

The Colossal Foundation, the nonprofit arm of the science fiction-y Dallas startup, announced Wednesday it had secured an additional $50 million in funding, bringing its total purse to $100 million.